Moderna's original Covid vaccine Marcos del Mazo/Getty

The Food and Drug Administration (FDA) just green-lit a new Covid vaccine from Moderna, the company said in a press release Saturday. Now the vaccine will bump up against an administration that is loath to recommend it.

The vaccine, called mNEXSPIKE, was approved for adults 65 and older, and people between 12 and 64 years old with “one or more underlying risk factor” defined by the Centers for Disease Control and Prevention (CDC), including conditions like cancer, asthma, and HIV. In a clinical trial of more than 11,000 participants, the vaccine showed higher efficacy than Moderna’s earlier vaccine.

According to Moderna CEO Stéphane Bancel, the shot offers an “important new tool to help protect people at high risk of severe disease.” Covid, as Bancel

© Mother Jones